Drug Shortages Affecting Emergency Med Up 2008 to 2014

This article originally appeared here.
Share this content:
Drug Shortages Affecting Emergency Med Up 2008 to 2014
Drug Shortages Affecting Emergency Med Up 2008 to 2014

WEDNESDAY, Jan. 27, 2016 (HealthDay News) -- From 2008 to 2014 there was an increase in drug shortages within the scope of emergency medicine (EM) practice, according to a study published in the January issue of Academic Emergency Medicine.

Kristy L. Hawley, M.P.H., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colleagues analyzed data from the University of Utah Drug Information Service from January 2001 to March 2014 to assess trends in EM drug shortages. Drug shortages were classified based on whether they were within the scope of EM practice, whether they were used for lifesaving interventions or high-acuity conditions, and whether a substitute existed.

Over the 159-month period, the researchers found that 33.9 percent of the 1,798 drug shortages were classified as within the scope of EM practice. Of these, 52.6 percent were for lifesaving interventions or for high-acuity conditions; 10.0 percent of those were for drugs that had no available substitute. From 2002 to 2007 the prevalence of EM drug shortages decreased. Between 2008 and 2014 the number of EM drug shortages increased from 23 to 123; shortages of drugs used as a direct lifesaving intervention or for high-acuity conditions increased from 14 to 69; and shortages of drugs with no available substitute increased from four to nine.

"Further work is needed to understand the impact of drug shortages on emergency department quality of care and outcomes," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »